利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.014 秒)

    BACILLUS SUBTILIS HA PRODUCING FIBRINOLYTIC ENZYME AND MUCILAGE HIGHLY, METHOD OF PREPARING FERMENTED SOYBEANS USING THE SAME STRAIN, AND SOYBEANS PREPARED BY THE METHOD
    1.
    发明申请
    BACILLUS SUBTILIS HA PRODUCING FIBRINOLYTIC ENZYME AND MUCILAGE HIGHLY, METHOD OF PREPARING FERMENTED SOYBEANS USING THE SAME STRAIN, AND SOYBEANS PREPARED BY THE METHOD 审中-公开
    生产纤维蛋白酶和高效制备芽孢杆菌的芽孢杆菌，使用相同菌株制备发芽大豆的方法，以及由该方法制备的大豆

    公开(公告)号：US20110111092A1

    公开(公告)日：2011-05-12

    申请号：US12515654

    申请日：2007-02-27

    申请人： Sam Pin Lee ,  Ji-Hyun Seo ,  In Seon Lee

    发明人： Sam Pin Lee ,  Ji-Hyun Seo ,  In Seon Lee

    IPC分类号： A23L1/20 ,  C12N1/20

    CPC分类号： C12R1/125 ,  A23L11/09 ,  A23L11/33

    摘要： The present invention provides Bacillus subtilis HA KCCM-10775P having a high productivity of protease, fibrinolytic enzyme and mucilage, a method preparing fermented soybeans (e.g., Cheonggukjang) using the same strain, in which bean fragments, soybeans and black soybeans are fermented, and fermented soybeans (e.g., Cheonggukjang) produced according to the said method. The Bacillus subtilis HA KCCM-10775P isolated from traditional fermented soybeans (e.g., Cheonggukjang) and identified is the superior strain having a high productivity of protease, fibrinolytic enzyme and mucilage. When preparing fermented soybeans (e.g., Cheonggukjang) using the strain of the present invention, it has good sensory properties by removing a peculiar smell thereof, as well as a high productivity of fibrinolytic enzyme and mucilage.

    摘要翻译： 本发明提供了具有高蛋白酶，纤维蛋白溶解酶和粘液生产力的枯草芽孢杆菌HAKCCM-10775P，使用相同菌株制备发酵大豆（例如Cheonggukjang）的方法，其中豆芽碎片，大豆和黑大豆被发酵，以及 按照上述方法生产的发酵大豆（例如Cheonggukjang）。 从传统发酵大豆（例如Cheonggukjang）分离的枯草芽孢杆菌HA KCCM-10775P，鉴定出具有高蛋白酶，纤维蛋白溶解酶和粘液生产力的优良菌株。 当使用本发明的菌株制备发酵大豆（例如Cheonggukjang）时，通过除去其特有的气味以及纤维蛋白溶解酶和粘液的高生产率具有良好的感官特性。

    Acid tolerant Lactobacillus sakei probio-65 with the ability of growth suppression of pathogenic microorganisms and the anti-allergic effect
    3.
    发明授权
    Acid tolerant Lactobacillus sakei probio-65 with the ability of growth suppression of pathogenic microorganisms and the anti-allergic effect 有权
    耐酸性乳酸杆菌probi-65具有生长抑制病原微生物的能力和抗过敏作用

    公开(公告)号：US08034606B2

    公开(公告)日：2011-10-11

    申请号：US11883398

    申请日：2006-01-27

    申请人： Yong Ha Park ,  In-seon Lee ,  Hong-ik Kim ,  Kook-hee Kang

    发明人： Yong Ha Park ,  In-seon Lee ,  Hong-ik Kim ,  Kook-hee Kang

    IPC分类号： C12N1/20

    CPC分类号： C12R1/225 ,  A23K10/18 ,  A23L33/135 ,  A61K8/99 ,  A61K35/747 ,  A61Q17/005 ,  A61Q19/00

    摘要： Disclosed are a novel tactic acid bacterium, Lactobacillus sakei Probio-65, and the use thereof. The L. sakei Probio-65 strain has acid tolerance, bile acid tolerance and antibiotic resistance, inhibits the growth of harmful pathogenic microorganisms in the body and the intestine of animals, and has immunuenhancing activity. In particular, the novel strain inhibits the growth of Staphylocccus aureus, which is known to be a factor aggravating atopic dermatitis. Thus, the novel strain is useful for preventing or treating atopic dermatitis and allergy-related disorders. Also, the novel strain stabilizes intestinal microflors by inhibiting the abnormal proliferation of harmful microorganisms in the intestine. The L. sakei Probio-65 strain or a culture thereof is useful in pharmaceutical, feed, food, and cosmetic compositions.

    摘要翻译： 公开了一种新型的乳酸菌，益气乳杆菌Probio-65及其用途。 李氏酵母Probio-65菌株具有耐酸性，胆汁酸耐受性和抗生素抗性，抑制动物身体和肠道中有害致病微生物的生长，并具有免疫增强活性。 特别地，新菌株抑制金黄色葡萄球菌的生长，其已知是加重特应性皮炎的因素。 因此，新型菌株可用于预防或治疗特应性皮炎和过敏相关疾病。 此外，新菌株通过抑制肠中有害微生物的异常增殖来稳定肠道微生物群落。 莱氏酵母Probio-65菌株或其培养物可用于药物，饲料，食品和化妆品组合物中。

    Novel Acid Tolerant Lactobacillus Sakei Probio-65 with the Ability of Growth Suppression of Pathogenic Microorganisms and the Anti-Allergic Effect
    6.
    发明申请
    Novel Acid Tolerant Lactobacillus Sakei Probio-65 with the Ability of Growth Suppression of Pathogenic Microorganisms and the Anti-Allergic Effect 有权
    新型耐酸性乳酸菌Sakei Probio-65具有生长抑制病原微生物能力和抗过敏作用

    公开(公告)号：US20090214497A1

    公开(公告)日：2009-08-27

    申请号：US11883398

    申请日：2006-01-27

    申请人： Yong Ha Park ,  In-seon Lee ,  Hong-ik Kim ,  Kook-hee Kang

    发明人： Yong Ha Park ,  In-seon Lee ,  Hong-ik Kim ,  Kook-hee Kang

    IPC分类号： A61K35/74 ,  C12N1/20 ,  A61K8/99

    CPC分类号： C12R1/225 ,  A23K10/18 ,  A23L33/135 ,  A61K8/99 ,  A61K35/747 ,  A61Q17/005 ,  A61Q19/00

    摘要： Disclosed are a novel tactic acid bacterium, Lactobacillus sakei Probio-65, and the use thereof. The L. sakei Probio-65 strain has acid tolerance, bile acid tolerance and antibiotic resistance, inhibits the growth of harmful pathogenic microorganisms in the body and the intestine of animals, and has immunuenhancing activity. In particular, the novel strain inhibits the growth of Staphylocccus aureus, which is known to be a factor aggravating atopic dermatitis. Thus, the novel strain is useful for preventing or treating atopic dermatitis and allergy-related disorders. Also, the novel strain stabilizes intestinal microflors by inhibiting the abnormal proliferation of harmful microorganisms in the intestine. The L. sakei Probio-65 strain or a culture thereof is useful in pharmaceutical, feed, food, and cosmetic compositions.

    摘要翻译： 公开了一种新型的乳酸菌，益气乳杆菌Probio-65及其用途。 李氏酵母Probio-65菌株具有耐酸性，胆汁酸耐受性和抗生素抗性，抑制动物身体和肠道中有害致病微生物的生长，并具有免疫增强活性。 特别地，新菌株抑制金黄色葡萄球菌的生长，其已知是加重特应性皮炎的因素。 因此，新型菌株可用于预防或治疗特应性皮炎和过敏相关疾病。 此外，新菌株通过抑制肠中有害微生物的异常增殖来稳定肠道微生物群落。 莱氏酵母Probio-65菌株或其培养物可用于药物，饲料，食品和化妆品组合物中。